Could Biogen’s Alzheimer’s Drug Be in Trouble?
It may be much ado about nothing, but Biogen Inc. ( BIIB, Financial) investors can’t help but be a bit…
BIIB,TSE:4523
Day of Reckoning Approaching for Biogen Alzheimer’s Drug
The FDA decision on Biogen Inc.’s (BIIB) Alzheimer’s treatment aducanumab is scheduled to come in the next few days. In…
